Breath Therapeutics is a biotechnology company focused on the development of aerosolized drugs to improve the treatment of rare and life-threatening pulmonary diseases. The Company develops the first therapy for treatment of Bronchiolitis Obliterans, which is a life-threatening lung disease without approved drug therapy.